NCT00070707 - Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280) | Biotech Hunter

Enrollment

188

Participants

Timeline

Start Date

April 3, 2003

Primary Completion Date

November 26, 2003

Study Completion Date

November 26, 2003

Conditions

Rhinitis, Allergic, SeasonalAsthma

Interventions

DRUG

Mometasone

Mometasone nasal spray 200 mcg/day administered as 2 sprays (50 mcg/spray) in each nostril.

DRUG

Placebo

Matching placebo nasal spray, administered QD as 2 sprays in each nostril.

DRUG

Albuterol/Salbutamol

Albuterol/salbutamol metered dose inhaler (90 mcg/puff) used as needed as asthma rescue medication.